Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 70 | ECE2020 | Next issue

22nd European Congress of Endocrinology

Online
05 Sep 2020 - 09 Sep 2020

Card image cap
Europe's leading endocrinology congress showcasing the very best in the study and treatment of endocrine disorders.

Audio ePoster Presentations

Adrenal and Cardiovascular Endocrinology

Residual corticosteroid production in autoimmune addison´s disease
1University of Bergen, Department of Clinical Science, Bergen, Norway; 2University of Bergen, KG Jebsen center for Autoimmune Disorders, Bergen, Norway; 3Karolinska Institutet, Department of Molecular Medicine and Surgery, Sweden; 4Örebro University Hospital, Department of Medicine, Örebro, Sweden;5Haukeland University Hospital, Department of Medicine, Bergen, Norway; 6Endocrinology in Charlottenburg, Berlin, Germany; 7Oslo University Hospital, Department of Endocrinology, Oslo, Norway; 8Karolinska University Hospital, Department of Endocrinology, Metabolism and Diabetes, Stockholm, Sweden; 9Vestfold Hospital Trust, Department of Medicine, Tønsberg, Norway; 10Haugesund Hospital, Department of Internal Medicine, Haugesund, Norway; 11Stavanger University Hospital, Department of Endocrinology, Stavanger, Norway; 12Sørlandet Hospital, Kristiansand, Department of Medicine, Kristiansand, Norway; 13Drammen Hospital, Vestre Viken Health Trust, Department of Medicine, Drammen, Norway; 14Akershus University Hospital, Department of Endocrinology, Lørenskog, Norway; 15Umeå University, Department of Public Health and Clinical Medicine, Umeå, Sweden; 16University Hospital of North Norway, Division of Internal Medicine, Tromsø, Norway; 17Tromsø Endocrine Research Group, UiT the Arctic University of Norway, Department of Clinical Medicine, Tromsø, Norway; 18Innlandet Hospital Trust, Section of Endocrinology, Hamar, Norway; 19Linköping University, Department of Endocrinology and Department of Health, Medicine and Caring Sciences, Linköping, Sweden; 20Sørlandet Hospital, Arendal, Department of Medicine, Arendal, Norway; 21Karolinska Institutet, Department of Medicine (Solna), Karolinska University Hospital, Stockholm, Sweden
ea0070aep1
Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
1Shamirmedical center, Department of Internal Medicine A, Zerifin, Israel; 2Tel-Aviv University, Sackler faculty of medicine, Tel Aviv, Israel; 3Shamir medical center, Diabetes unit, Zerifin, Israel; 4Shamir medical center, Endocrine Institute, Zerifin, Israel; 5Shamir medical center, Diagnostic Imaging, Zerifin, Israel; 6Shamir medical center, Obstetrics and Gynecology, Zerifin, Israel
ea0070aep2
Is there an epithelial to mesenchymal transition (EMT) in adrenocortical tumours?
1University Hospital Würzburg, Division of Endocrinology and Diabetes, Würzburg, Germany; 2University of Würzburg, Institute for Pathology, Würzburg, Germany; 3Helmholtz Zentrum München, Research Unit Analytical Pathology, München, Germany; 4University of Würzburg, Comprehenssive Cancer Center Mainfranken, Germany; 5University Hospital Würzburg, Clinical Chemistry and Laboratory Medicine, Würzburg, Germany
ea0070aep3
Copy number determination of steroid 21-hydroxylase gene for the genetic testing of congenital adrenal hyperplasia using real-time quantitative PCR
1Eotvos Lorand Research Network - Semmelweis University, Molecular Medicine Research Group, Budapest, Hungary; 2Semmelweis University, Department of Laboratory Medicine, Budapest, Hungary; 3Semmelweis University, 2nd Department of Internal Medicine, Budapest, Hungary
ea0070aep4
Cytochrome P450 (CYP) 2W1 affect steroid secretion in adrenocortical cell line and tumor tissues
1University Hospital of Würzburg, Division of Endocrinology and Diabetes, Department of Internal Medicine I, Würzburg, Germany; 2University of Turin, San Luigi Hospital, Department of Oncology, Turin, Italy; 3University Hospital of Würzburg, Central Laboratory, Würzburg, Germany; 4Catholic University of the Sacred Heart, Division of Endocrinology and Metabolism, Rome, Italy; 5Federico II University, Department of Clinical Medicine and Surgery, Naples, Italy; 6University of Turin, San Luigi Gonzaga Hospital, Division of Internal Medicine I, Turin, Italy; 7Institute of Metabolism and System Research, University of Birmingham, Birmingham, United Kingdom
ea0070aep5
Integrated genomics reveals different subgroups of primary bilateral macronodular adrenal hyperplasia (PBMAH)
1Cochin, Paris, France; 2Cochin hospital, Endocrinology, Paris, France; 3Integragen, Paris, France; 4Cochin hospital, Pathology, Paris, France; 5Cochin hospital, Hormonology, Paris, France; 6Lille Hospital, Endocrinology, Lille, France
ea0070aep6
Investigation of angiotensin II induced gene expression changes in vascular smooth muscle cells
1Semmelweis University, Department of Physiology, Budapest, Hungary; 2Semmelweis University, MTA-SE Laboratory of Molecular Physiology, Budapest, Hungary
ea0070aep7
Structural instability of mutant variants of 21-Hydroxylase
1Klinikum der Universität München, LMU München, Medizinische Klinik und Poliklinik IV, Munich, Germany; 2Technical University of Munich, Department of Chemistry, Garching, Germany; 3Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Division of Paediatric Endocrinology and Diabetes, Dresden, Germany
ea0070aep8
Persistent transcriptional disruption and histone mark modifications on visceral adipose tissue after remission of hypercortisolism
1Hospital Clinic/IDIBAPS, Endocrinology, Barcelona, Spain; 2Centro de Regulación Genomica, Barcelona, Spain; 3IDIBAPS/Laboratory of Endocrine Disorders, Barcelona, Spain; 4Hospital Clinic/Surgery, Barcelona, Spain
ea0070aep9
Adrenal cortex is responsive to human chorionic gonadotropin stimulation in patients with adrenal incidentalomas
1Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Department for Obesity, Metabolic and Reproductive Disorders, Serbia; 2Faculty of Medicine, University of Belgrade, Serbia; 3Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Serbia; 4University Hospital Centre Dr Dragisa Misovic
ea0070aep11
Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients.
1Cochin Institute, Paris, France; 2Cochin Hospital, Paris, France; 3Lille Hospital, Lille, France; 4Grenoble Hospital, Grenoble, France; 5Saint-Antoine Hospital, Paris, France; 6Rouen Hospital, Rouen, France; 7Ambroise Paré Hospital, Boulogne-Billancourt, France; 8Birmingham Women’s and Children’s NSH Foundation Trust, Birmingham, United Kingdom; 9UniversitätsSpital Zürich, Zürich, Switzerland; 10Endocrinology in Charlottenburg, Berlin, Germany; 11National and Kapodistrian University of Athens, Athens, Greece; 12Conception Hospital, Marseille, France; 13Nice Hospital, Nice, France; 14Curry Cabral Hospital, Lisboa, Portugal; 15Bordeaux Hospital, Bordeaux, France; 16Lyon Hospital, Lyon, France; 17Universitätsklinikum Würzburg, Würzburg, Germany; 18University of Birmingham, Birmingham, United Kingdom; 19Bicêtre Hospital, Le Kremlin-Bicêtre, France; 20University of Munich, Munich, Germany; 21Cochin Hospital, Division of Genetics, Paris, France
ea0070aep12
Comparability of steroid hormone measurement among 9 European laboratories using liquid chromatography-tandem mass spectrometry (LC-MS/MS): Impact of the blood derivative and of calibration
1Endocrinology Unit, Center for Applied Biomedical Research, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; 2Laboratory of Biostatistics, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; 3Laboratory of Clinical Biochemistry and Pharmacology, Department of Laboratory Medicine EOLAB, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; 4Institute of Laboratory Medicine, Hospital of the University of Munich (LMU), Munich, Germany; 5Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 6Manchester NHS Foundation Trust, Department of Clinical Biochemistry, University Hospital South Manchester, Manchester, United Kingdom; 7University Hospital of Lausanne (CHUV), Clinical Chemistry Laboratory, Lausanne, Switzerland; 8VU Medical Center - Academic Medical Center University Hospital, Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam, Netherlands; 9Canisius-Wilhelmina Hospital, Department of Clinical Chemistry, Nijmegen, Netherlands; 10University Hospital of Erlangen, Department of Pediatrics and Adolescent Medicine, Erlangen, Germany
ea0070aep14
Multiple hormonal deficiency in heart failure with preserved ejection fraction: Prevalence and role in modulation of antioxidant levels and myocardial dysfunction indexes
1Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Rome, Italy; 2Fondazione Policlinico Universitario A Gemelli IRCCS, Università Cattolica del Sacro Cuore, Dipartimento di Scienze biotecnologiche di base, cliniche intensivologiche e perioperatorie, Rome, Italy
ea0070aep15
Effects of adrenalectomy on arterial hypertension in patients with adrenal subclinical hypercortisolism: Preliminary results of a randomized clinical trial
1Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Unit of Endocrinology, Italy; 2Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico, Unit of Endocrinology, Milano, Italy; 3University of Milan, Department of Clinical Sciences and Community Health, Milano, Italy; 4Istituto Auxologico Italiano, IRCCS, Department of Endocrinology and Metabolism, Milano, Italy; 5IRCCS Istituto Ortopedico Galeazzi, Endocrinology and Diabetology Service, Milano, Italy; 6“Casa Sollievo della Sofferenza” IRCCS, Unità Operativa di Endocrinologia, San Giovanni Rotondo, Italy; 7University of Milan, Department of Biomedical, Surgical and Dental Sciences, Milano, Italy; 8Istituto Auxologico Italiano, IRCCS, Unit for Bone Metabolism Diseases and Diabetes & Lab of Endocrine and Metabolic Research, Milano, Italy
ea0070aep16
Aetiology, clinical presentation and mortality of Addison’s disease in India: A retrospective follow-up study over 14 years
1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Endocrinology, Lucknow, India; 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Microbiology, Lucknow, India; 3Sanjay Gandhi Postgraduate Istitute of Medical Sciences, Pathology, Lucknow, India; 4Barbara Davis Centre fro Childhood Diabetes, Denver, United States
ea0070aep18
Genes mediating cell growth in aldosterone-producing adenomas
1Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, Munich, Germany; 2Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy
ea0070aep19
Transcriptomic profiling of canine adrenocortical tumors
Faculty of Veterinary Medicine, Utrecht University, Clinical Sciences, Utrecht, Netherlands
ea0070aep20
Psychosocial determinants of body acceptance and quality of life in women with congenital adrenal hyperplasia
1Klinikum der Universität München, Medizinische Klinik und Poliklinik IV, München, Germany; 2Endokrinologie Charlottenburg, Berlin, Germany; 3Karolinska University Hospital, Astrid Lindgren Children’s Hospital, Pediatric Endocrinology Unit, Stockholm, Sweden; 4Karolinska Institutet, Department of Women’s and Children’s Health, Stockholm, Sweden; 5Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Amalia Children’s Hospital, Department of Pediatric Endocrinology, Nijmegen, Netherlands
ea0070aep21
The study of cell senescence in cortisol-producing adrenocortical adenoma
1Tohoku University, Graduate School of Medicine., Pathology; 2 Division of Internal Medicine, University of Torino, Medical Science; 3Tohoku University Graduate School of Medicine, Clinical Hypertension, Endocrinology and Metabolism; 4Tohoku University Hospital, Nephrology, Endocrinology, and Vascular Medicine; 5Tohoku Medical and Pharmaceutical University, Pathology
ea0070aep22
Mortality in patients with adrenal incidentalomas and autonomous cortisol secretion
1Skane University Hospital, Department of endocrinology, Lund, Sweden; 2Lund University, Faculty of medicine, department of clinical sciences, Lund, Lund, Sweden
ea0070aep23
Real life experience of 8 people with adrenal insufficiency using subcutaneous hydrocortisone infusion in continuous and pulsatile regimens recruited through hydrocortisone pump support group
1King’s College London - Waterloo Campus, London, United Kingdom; 2The London Clinic, London, United Kingdom; 3UK cortisol pump group, United Kingdom
ea0070aep24
Genetic alterations and clinical features in 16 brazilian patients with pheochromocytomas and paragangliomas
1Ricardo Castilho Center of Studies, Teresopolis, Brazil; 2Diagnosticos da America SA Division of Endocrinology Medical School Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 3i3S-Instituto de Investigação e Inovaçao em Saude, IPATIMUP - Institute of Molecular Pathology and Immunology, Department of Pathology Faculty of Medicine, Universidade do Porto, Porto, Portugal; 4i3S-Instituto de Investigação e Inovaçao em Saude, IPATIMUP - Institute of Molecular Pathology and Immunology, Institute of Biomedical Science, Universidade do Porto, Porto, Portugal; 5Endocrine Physiology Doris Rosenthal - IBFCCF Instituto de Biofisica Carlos Chagas Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 6Medical School - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 7 Division of Endocrinology Medical School Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
ea0070aep26
Peritoneal implantation of pheochromocytoma – two cases of pheochromocytomatosis
1Saint Imre Teaching Hospital, Metabolic Center, Budapest, Hungary; 2Semmelweis University, 2nd Department of Medicine, Budapest, Hungary; 3Semmelweis University, 1st Department of Surgery, Budapest, Hungary; 4Semmelweis University, Division of Nuclear Medicine, Department of Radiology, Budapest, Hungary
ea0070aep27
The role of cytotoxic chemotherapy in adjuvant treatment of radically resected adrenocortical carcinoma
1Division of Endocrinology, University Hospital Würzburg, Würzburg, Germany; 2Department of Endocrine Neoplasia and Hormonal Disorders, MD Anderson Cancer Center, Houston, United States
ea0070aep28
Treatment outcomes in 198 patients of the portuguese adrenocortical carcinoma register
1Institute of Oncology Francisco Gentil, Endocrinology, Lisboa, Portugal; 2Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; 3Hospital do Divino Espírito Santo, Ponta Delgada, Portugal; 4IPO Porto, Porto, Portugal; 5Hospital de Santa Maria, Lisboa, Portugal; 6Hospital Pedro Hispano, Senhora da Hora, Portugal; 7Saint John Hospital, Porto, Portugal; 8Braga Public Hospital, Braga, Portugal; 9Centro Hospitalar de Vila Nova de Gaia/Espinho Espinho, Portugal; 10Hospital Egas Moniz, Lisboa, Portugal; 11Hospital Curry Cabral, Lisboa, Portugal; 12Hospital Fernando da Fonseca, Amadora, Portugal; 13Hospital Garcia de Orta, Almada, Portugal; 14Hospital Geral de Santo António, Porto, Portugal; 15Ipo Coimbra - Instituto Português De Oncologia De Coimbra Francisco Gentil, E.P.E., Coimbra, Portugal; 16Hospital da Luz Lisboa, Lisboa, Portugal; 17Hospital Viana ULSAM, Viana do Castelo, Portugal; 18Centro Hospitalar do Tâmega e Sousa, Portugal
ea0070aep29
Excess glucocorticoid activity may suppress tumor immune activity in adrenocortical carcinoma
1Corcept Therapeutics, Menlo Park, United States; 2The University of Texas, MD Anderson Cancer Center, Houston, United States; 3Ardigen, Kraków, Poland
ea0070aep30
Functional ectopic adrenocortical carcinoma; A case report
1Mater Dei Hospital, MSD2090, Malta; 2University of Malta, Msida, Malta
ea0070aep31
A rare case of functioning adrenocortical oncocytoma of uncertain malignant potential in a young female diagnosed with type 1 neurofibromatosis
1CI Parhon National Institute of Endocrinology, C Davila University of Medicine and Pharmacy, Pituitary and Neuroendocrine Diseases, Bucharest, Romania; 2Sf. Ioan Emergency Hospital, Surgery, Bucharest, Romania; 3Professor Doctor Theodor Burghele Hospital, Urology, Bucharest, Romania
ea0070aep32
Adrenocortical cancer mimicking lymphoma on magnetic resonance scan
University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Endocrinology and Metabolism, Turkey
ea0070aep33
Cushing’s syndrome during pregnancy - case presentation and follow-up.
1“Pius Brânzeu” Emergency Clinical County Hospital Department of Endocrinology, Timisoara, Romania; 2Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara (Romania), Department of Endocrinology, Timisoara, Romania; 3Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Discipline of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, Timisoara, Romania
ea0070aep34
Identification of the genetic signature of vascular calcification in patients with type 2 diabetes mellitus by a computational approach
1Fundación Pública Andaluza para la investigación Biosanitaria Andalucía Oriental (FIBAO), Granada, Spain; 2Instituto de Investigación Biosanitaria de Granada, Granada, Spain; 3Hospital Universitario San Cecilio de Granada, Granada, Spain; 4Instituto de Salud Carlos III, CIBERFES, Madrid, Spain; 5University of Granada, Department of Medicine, Granada, Spain; 6Hospital Universitario San Cecilio de Granada, Endocrinology and Nutrition, Granada, Spain
ea0070aep36
Physiologically based pharmacokinetic modelling to inform dosing in adrenal insufficiency and congenital adrenal hyperplasia
1Diurnal Limited, Cardiff, United Kingdom; 2Certara UK Limited, Simcyp Division, Sheffield, United Kingdom; 3University of Sheffield, The Medical School, Sheffield, United Kingdom
ea0070aep37
An unusual case of Cushing’s syndrome secondary to ACTH producing prostate adenocarcinoma
1Singhealth, Endocrinology, Singapore; 2Changi General Hospital, Endocrinology, Singapore
ea0070aep38
Effects of endogenous hypercortisolism on selected Angio-miRs expression in humans
1Pomeranian Medical University, Department of General Pathology, SZCZECIN, Poland; 2Pomeranian Medical University, Department of Endocrinology, Metabolic Diseases and Internal Diseases, SZCZECIN, Poland; 3Pomeranian Medical University, Department of Gynecological Surgery and Gynecological Oncology, SZCZECIN, Poland; 4Pomeranian Medical University, Department of Paediatrics, Endocrinology, Diabetology, Metabolic Diseases, and Cardiology of Developmental Age, SZCZECIN, Poland
ea0070aep39
Somatostatin receptors 2A and 5 expression in adrenocortical cancer
Endocrinology Research Centre, Moscow, Russian Federation
ea0070aep41
Prognostic value of Ki-67 and ENSAT stage on recurrence-free survival and overall survival in patients with adrenocortical carcinoma
1UHC Zagreb, Department of Endocrinology; 2School of Medicine, University of Zagreb, Croatia; 3UHC Zagreb, Department of Urology; 4UHC Zagreb, Department of Radiology
ea0070aep42
Etiology and extent of impaired quality of life, fatigue and affective, cognitive, and emotional dysfunction in patients with cushing’s syndrome – The IQFACE-CS study
1Leiden University Medical Center (LUMC), Endocrinology, Leiden, Netherlands; 2Sahlgrenska University Hospital, Endocrinology, Göteborg, Sweden; 3Hospital de la Santa Creu i Sant Pau, Endocrinology, Barcelona, Spain; 4Leiden University Medical Center (LUMC), Psychiatry, Leiden, Netherlands; 5Sahlgrenska Academy, Clinical Neuroscience and Rehabilitation, Göteborg, Sweden; 6Hospital de la Santa Creu i Sant Pau, Radiolagical Imaging, Barcelona, Spain
ea0070aep44
Fertility testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
1Semmelweis University, 2nd Department of Medicine, Budapest, Hungary; 2Semmelweis University, ELRN-SE Molecular Medicine Research Group; 3Semmelweis University, Department of Laboratory Medicine; 4Semmelweis University, Department of Urology and Urooncology
ea0070aep46
Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas
1The University of Queensland Diamantina Institute, Endocrine Hypertension Research Centre, Brisbane, Australia; 2Princess Alexandra Hospital, Department of Endocrinology & Diabetes, Brisbane, Australia; 3Princess Alexandra Hospital, Hypertension Unit, Brisbane, Australia; 4The University of Queensland, Faculty of Medicine, Brisbane, Australia
ea0070aep47
Early renin recovery after adrenalectomy in patients with aldosterone-producing adenoma - a longitudinal study.
1Ribeirao Preto Medical School - University of Sao Paulo, Internal Medicine, Ribeirao Preto, Brazil; 2Ribeirao Preto Medical School - University of Sao Paulo, Surgery and Anatomy, Ribeirao Preto, Brazil; 3Ribeirao Preto Medical School - University of Sao Paulo, Pedriatrics, Ribeirao Preto, Brazil
ea0070aep48
Comparison of incidence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma across different BMI and age distribution
1Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia Slovenia; 2University Medical Center Ljubljana, Ljubljana, Slovenia, Department of Endocrinology, Diabetes and Metabolic Disease, Ljubljana, Slovenia; 3Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, Pharmacogenetics Laboratory, Institute of Biochemistry, Slovenia
ea0070aep49
Isolated acquired hypoaldosteronism as a cause of hypovolemic hyponatremia with urinary sodium loss
1Hospital universitario Clínico San Carlos, Endocrinología, Madrid, Spain; 2Hospital universitario Fundación Jimenez Díaz, Endocrinología, Madrid, Spain
ea0070aep51
Ambulance alert system enabling pre-hospital parenteral steroids for patients with adrenal insufficiency
1St Helens and Knowsley Teaching Hospitals NHS Trust, Diabetes and Endocrinology, St Helens, United Kingdom; 2St Helens and Knowsley Teaching Hospitals NHS Trust, Information Governance, St Helens, United Kingdom; 3North West Ambulance Service NHS Trust (NWAS), United Kingdom
ea0070aep52
Trends in the incidence of adrenal incidentaloma diagnosed by CT abdomen in 2002 and 2015: Preliminary data from a retrospective study in regional sweden
1Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden; 2Falun Hospital, Department of Medicine, Falun, Sweden; 3Center for Clinical Research Dalarna, Falun, Sweden; 4Karolinska University Hospital, Department of Endocrinology, Metabolism and Diabetes D2:04, Stockholm,
ea0070aep53
Sympathoadrenal system function in patients with multiple sclerosis
1Biomedical Research Center, Slovak Academy of Sciences, Institute of Clinical and Translational Research, Bratislava, Slovakia; 2Faculty of Medicine, Comenius University, 1st Department of Neurology, Bratislava, Slovakia
ea0070aep54
Steroidogenic proteins expression pattern in adrenocortical carcinomas
1Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP), Porto, Portugal; 2Instituto de Investigação e Inovação em Saúde (I3S), Porto, Portugal; 3Instituto de Ciências Biomédicas Abel Salazar, Department of Anatomy, Porto, Portugal; 4Unit for Multidisciplinary Research in Biomedicine (UMIB), Endocrine, Cardiovascular & Metabolic Research, Porto, Portugal; 5GV (Sonny) Montgomery VA Medical Center and University of Mississippi Medical Center, Endocrinology Section, Jackson, United States; 6Hospital S João, Department of Endocrinology, Porto, Portugal; 7Faculty of Medicine of the University of Porto, Department of Biomedicine, Porto, Portugal
ea0070aep55
Crinecerfont (NBI-74788), a novel CRF1 receptor antagonist, reduces adrenal androgens and precursors in patients with classic congenital adrenal hyperplasia: Results from a phase 2, multiple-dose study
1University of Michigan Medical School, Ann Arbor, United States; 2University of Minnesota Masonic Children’s Hospital, Minneapolis, United States; 3University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, United States; 4The Children’s Hospital of Philadelphia, Philadelphia, United States; 5Neurocrine Biosciences, Inc., San Diego, United States
ea0070aep56
Possible protective influence of KCNJ5 and CACNA1D gene polymorphisms on lipid profile in primary aldosteronism and essential hypertensive patients
1Wroclaw Medical University, Department and Clinic of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wrocław, Poland; 2Polish Academy of Sciences, Laboratory of Clinical Immunogenetics and Pharmacogenetics, Institute of Immunology and Experimental Therapy, Wrocław, Poland
ea0070aep57
Steroid hormones influence systemic sclerosis prevalence
1Department of Endocrinology, Medical University of Graz, Graz, Austria; 2Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria; 3Department of Experimental Anaesthesiology, Medical University of Graz, Graz, Austria; 4Otto Loewi Research Center, Medical University of Graz, Graz, Austria
ea0070aep58
Algorithm of staged perioperative hemodynamic management (SPOHM)
1Bogomolets National Medical University, Ukraine; 2Bogomolets National Medical University, anesthesiology and intensive care, Kyiv, Ukraine; 3Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine organs and tissues of MoH of Ukraine
ea0070aep59
Surgical outcomes of adrenalectomy for primary hyperaldosteronism after using novel diagnostic tests
1Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Endocrine Unit, 1st Department of Propaedeutic Medicine; 2G Gennimatas Hospital, Department of Endocrinology and Diabetes Center; 3Athens General Hospital “G Gennimatas”, Third Department of Surgery
ea0070aep63
Subtyping of primary aldosteronism in patients with partially successful adrenal vein sampling
1Department of Endocrinology, University Clinical Hospital Center Zagreb; 2School of Medicine, University of Zagreb; 3Department of Internal Medicine, General Hospital Dubrovnik
ea0070aep64
Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia
1Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Department of Internal Medicine and Clinical Nutrition, Gothenburg, Sweden; 2Sahlgrenska University Hospital, Department of Endocrinology, Gothenburg, Sweden; 3Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Gothenburg, Sweden; 3Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Gothenburg, Sweden; 5University of Campania “Luigi Vanvitelli”, Department of Advanced Medical and Surgical Sciences, Naples, Italy
ea0070aep65
Does adrenal vein sampling really improve the final approach for treating prymary aldosteronism? a retrospective study.
1Hospital Parc Taulí de Sabadell, Endocrinology and Nutrition, Sabadell, Spain; 2Hospital Parc Taulí de Sabadell, Radiology, Sabadell, Spain; 3Hospital Parc Taulí de Sabadell, Nefrology, Sabadell, Spain; 4Hospital Parc Taulí de Sabadell, Laboratory, Sabadell, Spain
ea0070aep68
Pulsatile subcutaneous hydrocortisone replacement in primary adrenal failure, a proof of concept pilot trial
1University of Bergen, Department of Clinical Science, Bergen, Norway; 2Haukeland University Hospital / Health Bergen, Departments of Medicine and Centre for Clinical Research, Norway; 3Haukeland University Hospital/Health Bergen, Endocrinology Department, Norway
ea0070aep69
CAH-X Syndrome in a german cohort of patients with 21--hydroxylase deficiency
1Klinikum der Universität München, Medizinische Klinik und Poliklinik IV, Munich, Germany; 2Dr. v. Hauner Children’s Hospital, LMU - University of Munich, Department of Pediatric Neurology and Developmental Medicine, Munich, Germany; 3Medizinisch Genetisches Zentrum, Munich, Germany
ea0070aep70
Adrenal incidentalomas and renal cysts – the definitive sign of aging?
1Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Department for Obesity, Metabolic and Reproductive Disorders, Belgrade, Serbia; 2Faculty of Medicine, University of Belgrade, Serbia, Belgrade, Serbia; 3Centre for Radiology and Magnetic Resonance Imaging, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Serbia, Belgrade, Serbia; 4Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Serbia, Belgrade, Serbia; 5Clinic for Nephrology, Clinical Centre of Serbia, Belgrade, Serbia; 6University Hospital Centre Dr Dragisa Misovic, Belgrade, Serbia
ea0070aep72
Major barriers exist in the diagnosis and management of addison’s disease in africa
1University of Cape Town, Department of Medicine, Cape Town, South Africa; 2University of the Free State, Department of Medicine, Bloemfontein, South Africa; 3Dubai Medical College, Dubai, United Arab Emirates
ea0070aep73
Differential diagnosis of primary adrenal insufficiency in a young male with mental retardation and axonal sensorimotor polyneuropathy
1CI Parhon National Institute of Endocrinology, Pituitary and Neuroendocrinology, București, Romania; 2Carol Davila University of Medicine and Pharmacy, Endocrinology, București, Romania
ea0070aep75
Adrenal necrosis caused by streptococcus constellatus infection
National Taiwan University Hospital, Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei, Taiwan
ea0070aep78
Endothelial vascular adrenal cyst with unusual presentation
1Meuhedet HMO, Endocrinology, Israel; 2Meuhedet HMO, Diabetic Clinic; 3Hadassah-Hebrew University Medical Center, Pathology; 4Hadassah-Hebrew University Medical Center, Mount Scopus, Endocrine and General Surgery
ea0070aep79
Less common form of adult secondary hypertension
CHU Brugmann, Endocrinology, Bruxelles, Belgium
ea0070aep80
Malignant collision tumour in left adrenal gland- A rare tumour
University Hospital Southampton, Endocrinology, Southampton, United Kingdom
ea0070aep82
JIL-O: Establishment of a new steroidogenic human adrenocortical carcinoma cell line
1University Hospital, University of Würzburg, Department of Internal Medicine I, Division of Endocrinology and Diabetes, Würzburg, Germany; 2University Hospital, University of Würzburg, Clinical Chemistry and Laboratory Medicine, Würzburg, Germany; 3 University of Würzburg, Comprehensive Cancer Center Mainfranken, Würzburg, Germany
ea0070aep83
Prognostic factors and overall survival in patients with adrenocortical cancer: Experiences of a single tertiary referral endocrine centre in Hungary (1974–2019)
1Semmelweis University, 2nd Department of Medicine, Budapest, Hungary; 2Semmelweis University, 1st Department of Pathology and Experimental Cancer Research, Budapest, Hungary; 3Semmelweis University, Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, Budapest, Hungary; 4Semmelweis University, 1st Department of Surgery, Budapest, Hungary; 5Semmelweis University, 2nd Department of Pathology, Budapest, Hungary; 6Semmelweis University, Division of Nuclear Medicine, Department of Radiology, Budapest, Hungary
ea0070aep84
The effect of surgeon’s experience on the outcome of patients with ACC
1University Hospital Centre Zagreb, Department of Endocrinology; 2University Hospital Centre Zagreb, Department of Urology; 3School of Medicine, University of Zagreb; 4University Hospital Centre Zagreb, Department of Radiology
ea0070aep85
VDR-GR complex reduces apoptosis in acute myeloid leukemia cells via reduction of GR transcriptional activity
1National and Kapodistrian University of Athens, Medical School, Department of Biological Chemistry, Athina, Greece; 2National and Kapodistrian University of Athens, Medical School, 1st Department of Internal Medicine, “Laiko” Hospital, Athina, Greece; 3National and Kapodistrian University of Athens, Medical School, Department of Physiology, Athina, Greece; 4Warwick Medical School, Division of Translational and Experimental Medicine- Metabolic and Vascular Health, United Kingdom
ea0070aep86
Cortisol response to acute stress is dependent on previous stress exposure and sex of the examined humans
1Clinic for Endocrinology, Diabetes, and Metabolic Diseases, Department for Endocrine Tumors and Hereditary Cancer Syndromes, Belgrade, Serbia; 2Clinic for Endocrinology, Diabetes, and Metabolic Diseases, Belgrade, Serbia; 3Clinic for cardiology, Belgrade, Serbia
ea0070aep87
Investigating differences regarding stress hormonal response during vaginal delivery and elective caesarean section
1Unit of Endocrinology, Diabetes mellitus and Metabolism, Second Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; 2General Maternal Hospital of Athens “Elena Venizelou”, Fifth Department of Obstetrics and Gynecology, Athens, Greece; 3 Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, Assisted Reproduction Unit, Second Department of Obstetrics and Gynecology, Athens, Greece; 4Medical School, National and Kapodistrian University of Athens, Laboratory of Experimental Physiology, Athens, Greece; 5Genesis Athens Clinic, Centre for Human Reproduction, Chalandri, Athens, Greece
ea0070aep88
Apparent mineralocorticoid excess (AME): Finding the “root” cause
Midland Regional Hospital Portlaoise, Diabetes & Endocrinology, Portlaoise, Ireland
ea0070aep89
Hypertensive crises related to the defecation strain, what’s the diagnosis?
1Endocrinology & Nutrition Dpt., Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria., Las Palmas de Gran Canaria, Spain; 2Outpatient Hypertension Clinic, Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria
ea0070aep90
Composite pheochromocytoma of the adrenal gland: Case report
1 Sf. Spiridon’ Emergency Hospital, Iași, Romania; 2 Grigore T Popa’ University of Medicine and Pharmacy, Iasi, Romania
ea0070aep91
Cystic pheochromocytoma, a diagnostic challenge: A case report
1University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, Macedonia; 28th September General City Hospital, Department of Endocrinology, Skopje, Macedonia; 38th September General City Hospital, Department of Anesthesiology, Skopje, Macedonia; 4University Clinic of Gatstroenterology, Skopje, Macedonia
ea0070aep92
Type 1 neurofibromatosis and malignant pheochromocytoma
1Centro Hospitalar e Universitário de Coimbra, Endocrinology, Coimbra, Portugal; 2Instituto Português de Oncologia de Lisboa Francisco Gentil, Endocrinology, Lisbon, Portugal
ea0070aep93
Results of biochemical testing in suspected primary hyperaldosteronism – a retrospective study
1CI Parhon National Institute of Endocrinology, Bucharest, Romania; 2Sf Ioan Emergency Hospital, Surgery, Bucharest, Romania; 3CC Iliescu Institute of Cardiology, Bucharest, Romania; 4Carol Davila University of Medicine, Bucharest, Romania; 5Carol Davila Nephrology Hospital, Bucharest, Romania
ea0070aep94
Body composition, insulin sensitivity and blood pressure in patients with congenital adrenal hyperplasia
1Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania; 2Department of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania; 3Department of Nursing and Care, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
ea0070aep95
Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS
1University Hospital Würzburg, Division of Endocrinology and Diabetes, Germany; 2University Hospital Würzburg, Central Laboratory, Core Unit Clinical Mass Spectrometry; 3University Medicine Greifswald, Institute of Clinical Chemistry and Laboratory Medicine, Germany
ea0070aep96
Clinical and histopathologic phenotype of a single-center patient cohort operated for unilateral primary aldosteronism
1Department of Medicine IV, University Hospital, LMU Munich, Munich, Germany; 2Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy
ea0070aep97
Expression ofestrogen-related receptors andepidermal growth factor receptorin normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy
1General Hospital of Athens “G Gennimatas”, 3rd Department of Surgery, Athina, Greece; 2Medical School, Department of Biological Chemistry, Athina, Greece; 3Evaggelismos General Hospital, Department of Pathology, Athina, Greece; 4Medical School, 1st Department of Internal Medicine, Laiko University Hospital, Athina, Greece; 5General Hospital of Athens “G Gennimatas”, 3rd Department of Surgery, Athina, Greece; 6General Hospital of Athens “G Gennimatas”, Department of Pathology, Athina, Greece; 7General Hospital of Athens “G Gennimatas”, Department of Endocrinology and Diabetes Center, Athina, Greece; 8Warwick Medical School, Division of Translational and Experimental Medicine- Metabolic and Vascular Health, United Kingdom; 9Medical School, 1st Department of Propaedeutic Internal Medicine, Laiko University Hospital, Athina, Greece
ea0070aep98
Assessment of serum adropin concentrations in primary aldosteronism
Centre of Postgraduate Medical Education, Department of Endocrinology, Warsaw, Poland
ea0070aep99
Radiological and functional analysis of a cohort of adrenal adenomas
1Department of Medicine, University of Malta Medical School, Mater Dei Hospital, Msida, Malta; 2Neuroendocrine Clinic, Mater Dei Hospital, Msida, Malta
ea0070aep100
Aetiological diagnosis of Cushing’s syndrome : A trap for the unwary
University Hospital Fattouma Bourguiba Monastir, Departments of Internal Medicine and Endocrinology, Monastir, Tunisia
ea0070aep101
Evaluation of clinical and functional differences between unilateral and bilateral adrenal incidentalomas. A spanish multicentric study.
1Hospital Universitario Ramón y Cajal, Endocrinology, Madrid, Spain; 2Hospital Clínico Universitario de Salamanca, Endocrinology, Salamanca, Spain; 3Hospital Universitario de la Paz, Endocrinology, Madrid, Spain; 4Hospital Universitario Gregorio Marañón, Endocrinology, Madrid, Spain; 5Hospital Royo Villanova, Endocrinology, Zaragoza, Spain; 6Hospital Universitario Nuestra Señora de Valme, Endocrinology, Sevilla, Spain; 7Hospital Universitario de la Princesa, Endocrinology, Madrid, Spain
ea0070aep103
Human centered design in co-creation of tool-kit for care of patients with adrenal insufficiency- an iterative quality improvement approach
1University of Alberta, Division of Endocrinology and Metabolism, Department of Medicine, Edmonton, Canada; 2University of Alberta, Physician Learning Program, Edmonton, Canada
ea0070aep105
Study of effect of whitening creams on serum basal cortisol level in egyptian females
Ain Shams University Faculty of Medicine, internal medicine, Cairo, Egypt
ea0070aep106
Paradoxical hypertension: The hidden risk of beta blockade
1Hospital Dr Negrín, Endocrinology, Las Palmas de GC, Spain; 2Centro de Salud Escaleritas, Las Palmas de GC, Spain; 3Consultorio Local, Bañaderos, Consultorio Local, Bañaderos, Arucas, Spain; 4Hospital San Roque, Endocrinology, Las Palmas de GC, Spain; 5Hospital Dr Negrín, Outpatient Hypertension Clinic, Las Palmas de GC, Spain
ea0070aep108
Case study of family performing pheochromocytoma and paraganglioma (PPGL)
1Medical University of Lublin, Chair of Internal Medicine and Department of Internal Medicine in Nursing, Lublin, Poland; 2Medical Univerity of Lublin, Chair and Department of Endocrinology, Lublin, Poland; 3Medical Univerity of Lublin, Chair and Department of Epidemiology and Clinical Research Methodology, Lublin, Poland
ea0070aep109
Pheochromocytoma with subclinical cushing’s syndrome: A case report
Monastir, Internal Medicine-Endocrinology Department, Monastir, Tunisia
ea0070aep110
A rare case of spontaneous adrenal haemorrhage from an adrenal haematoma
Changi General Hospital, Endocrinology, Singapore, Singapore
ea0070aep111
A patient with seizures and adrenal failure as systemic manifestations of miliary tuberculosis: A case report
1Barts and the London Medical School, London UK, London, United Kingdom; 2Queen`s Hospital, London, United Kingdom; 3Queen`s Hospital, Diabetes and Endocrinology/Acute Medicine, London, United Kingdom
ea0070aep112
Misdiagnosis of phaeochromocytoma with multiple cerebral infarcts and complex arrhythmias, failure “to think of it”
1Betsi Cadwaladr University Health Board, Endocrinology, Bangor, United Kingdom; 2Betsi Cadwaladr University Health Board, Clinical Chemistry, Bangor, United Kingdom
ea0070aep113
Adjuvant mitotane therapy: Predictive factors of response in adrenocortical carcinoma
1Coimbra Hospital and University Centre, Endocrinology Department, Coimbra, Portugal; 2Faculty of Medicine of the University of Coimbra, Endocrinology Department, Coimbra, Portugal; 3Coimbra Hospital and University Centre, Pathological Anatomy Department, Coimbra, Portugal; 4Coimbra Hospital and University Centre, Urology Department, Coimbra, Portugal
ea0070aep116
Diagnosis, treatment and survival of adrenocortical carcinoma: 28 years of experience
1Centro Hospitalar e Universitário de Coimbra EPE, Coimbra, Portugal, Endocrinology, Diabetes and Metabolism Department; 2Centro Hospitalar e Universitário de Coimbra EPE, Coimbra, Portugal, Pathologic Anatomy Department; 3Centro Hospitalar e Universitário de Coimbra EPE, Coimbra, Portugal, Urology Department
ea0070aep117
CT signs and parameters of vascularization of pulmonary neuroendocrine tumours and their relationship with the development of ACTH ectopic syndrome
1Endocrinology Research Centre, radiology, Moscow, Russian Federation; 2, Radiology; 3Endocrinology Research Centre, Clinical and diagnostic center, Moscow, Russian Federation; 4Vishnevsky Institute of Surgery, Thoracic surgery, Moscow, Russian Federation
ea0070aep118
Melatonin inhibits vascular smooth muscle cell proliferation and apoptosis through upregulation of Sestrin2
1Daegu Fatima Hospital, Internal Medicine , Daegu, Korea, Rep. of South; 2Keimyung University School of Medicine , Internal Medicine , Daegu, Korea, Rep. of South; 3Kyungpook National University School of Medicine, Internal Medicine, Daegu, Korea, Rep. of South
ea0070aep121